John Fair - Jan 24, 2023 Form 4 Insider Report for Dare Bioscience, Inc. (DARE)

Role
Chief Commercial Officer
Signature
/s/ John Fair
Stock symbol
DARE
Transactions as of
Jan 24, 2023
Transactions value $
$0
Form type
4
Date filed
1/26/2023, 03:05 PM
Previous filing
Jan 28, 2022
Next filing
Mar 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DARE Stock Option (right to buy) Award $0 +290K $0.00 290K Jan 24, 2023 Common stock 290K $1.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.